4-3767191-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000683.4(ADRA2C):āc.585C>Gā(p.Asp195Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,610,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000683.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADRA2C | NM_000683.4 | c.585C>G | p.Asp195Glu | missense_variant | 1/1 | ENST00000330055.7 | NP_000674.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADRA2C | ENST00000330055.7 | c.585C>G | p.Asp195Glu | missense_variant | 1/1 | 6 | NM_000683.4 | ENSP00000386069.2 | ||
ADRA2C | ENST00000509482.1 | c.585C>G | p.Asp195Glu | missense_variant | 1/2 | 3 | ENSP00000426268.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 242946Hom.: 0 AF XY: 0.00000752 AC XY: 1AN XY: 132892
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1457872Hom.: 0 Cov.: 32 AF XY: 0.0000221 AC XY: 16AN XY: 725278
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.585C>G (p.D195E) alteration is located in exon 1 (coding exon 1) of the ADRA2C gene. This alteration results from a C to G substitution at nucleotide position 585, causing the aspartic acid (D) at amino acid position 195 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at